These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 7519124

  • 1. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL.
    Cancer Res; 1994 Aug 15; 54(16):4539-46. PubMed ID: 7519124
    [Abstract] [Full Text] [Related]

  • 2. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H.
    Gynecol Oncol; 1995 Jun 15; 57(3):383-7. PubMed ID: 7539775
    [Abstract] [Full Text] [Related]

  • 3. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ, Rustgi AK.
    Cancer Res; 1995 May 01; 55(9):1831-5. PubMed ID: 7537174
    [Abstract] [Full Text] [Related]

  • 4. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA.
    Int J Cancer Suppl; 1994 May 01; 8():110-5. PubMed ID: 7515025
    [Abstract] [Full Text] [Related]

  • 5. New CD44 splice variants associated with human breast cancers.
    Iida N, Bourguignon LY.
    J Cell Physiol; 1995 Jan 01; 162(1):127-33. PubMed ID: 7529235
    [Abstract] [Full Text] [Related]

  • 6. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF, Zhu D, Bourguignon LY.
    J Cell Physiol; 1995 Sep 01; 164(3):605-12. PubMed ID: 7544357
    [Abstract] [Full Text] [Related]

  • 7. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1996 Mar 01; 56(5):1037-42. PubMed ID: 8640758
    [Abstract] [Full Text] [Related]

  • 8. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A, Gobl A, Eriksson B, Skogseid B, Oberg K.
    Cancer Res; 1994 Feb 15; 54(4):981-6. PubMed ID: 7508823
    [Abstract] [Full Text] [Related]

  • 9. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M, Diaz-Mitoma F, Kumar A.
    Immunology; 1995 Sep 15; 86(1):41-8. PubMed ID: 7590880
    [Abstract] [Full Text] [Related]

  • 10. [Expression of CD44 alternative splicing variants in lung cancer].
    Ohgami A, Sugio K, Mitsudomi T, Tsuda T, Yasumoto K.
    Nihon Rinsho; 1995 Jul 15; 53(7):1704-9. PubMed ID: 7630011
    [Abstract] [Full Text] [Related]

  • 11. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
    Dall P, Heider KH, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P.
    Cancer Res; 1994 Jul 01; 54(13):3337-41. PubMed ID: 7516819
    [Abstract] [Full Text] [Related]

  • 12. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 13. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL, Lokeshwar VB, Block NL.
    Anticancer Res; 1995 Aug 15; 15(4):1191-8. PubMed ID: 7544562
    [Abstract] [Full Text] [Related]

  • 14. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A.
    Cancer Res; 1994 Jul 15; 54(14):3922-8. PubMed ID: 7518345
    [Abstract] [Full Text] [Related]

  • 15. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D.
    Cancer Res; 1994 Aug 01; 54(15):4238-42. PubMed ID: 7518353
    [Abstract] [Full Text] [Related]

  • 16. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ, Koopmann R, Imhof BA, Günthert U.
    J Pathol; 1994 Oct 01; 174(2):89-100. PubMed ID: 7525912
    [Abstract] [Full Text] [Related]

  • 17. CD44 splice variants: expression during lymphocyte activation and tumor progression.
    Pals ST, Koopman G, Heider KH, Griffioen A, Adolf GR, Van den Berg F, Ponta H, Herrlich P, Horst E.
    Behring Inst Mitt; 1993 Aug 01; (92):273-7. PubMed ID: 7504454
    [Abstract] [Full Text] [Related]

  • 18. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL.
    Biochem Biophys Res Commun; 1994 Apr 29; 200(2):1015-22. PubMed ID: 7513991
    [Abstract] [Full Text] [Related]

  • 19. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N.
    J Cell Biol; 1995 Feb 29; 128(4):673-85. PubMed ID: 7532175
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM, Givehchian M, Dürst M, Schneider A, Costa S, Melsheimer P, Lacroix J, Zöller M, Doeberitz MK.
    Clin Cancer Res; 1995 Oct 29; 1(10):1125-32. PubMed ID: 9815903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.